A Study to Investigate Safety and Tolerability of SH3765 Tablet in Patients With Advanced Malignant Tumor

NCT05015309 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignant Tumor

Interventions

DRUG: SH3765 tablet

Sponsor

Nanjing Sanhome Pharmaceutical, Co., Ltd.